FDA Expands Approved Use of Kalydeco to Treat Additional Mutations of Cystic Fibrosis

Article Link: FDA Expands Approved Use of Kalydeco to Treat Additional Mutations of Cystic Fibrosis



Source: FDA New Drug Approvals